ENTITY

Tenax Therapeutics (TENX US)

4
Analysis
Health Care • United States
Tenax Therapeutics, Inc. operates as a specialty pharmacuitical company. The Company develops and commercializes products for the critical care market. Tenax Therapeutics develops treatments for treatment of Pulmonary Hypertension associated with Heart Failure and preserved Ejection Fraction (PH-HFpEF) using levosimendan.
more
Exchange Announcement • 09 Oct 2026 04:15

Current Report (Form 8-K | Period ending 2026-10-08)

Exchange Announcement • 09 Sep 2026 20:00

Current Report (Form 8-K | Period ending 2026-09-09)

Exchange Announcement • 10 Aug 2026 19:19

Current Report (Form 8-K | Period ending 2026-08-10)

Exchange Announcement • 31 Jul 2026 23:25

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 31 Jul 2026 19:23

Current Report (Form 8-K | Period ending 2026-07-31)

x